SAB Biotherapeutics Inc. (SABSW)
NASDAQ: SABSW
· Real-Time Price · USD
0.02
-0.02 (-48.98%)
At close: Jun 09, 2025, 11:03 AM
SAB Biotherapeutics Fail-to-Deliver
Total FTD Shares
290
Below Average
FTD / Avg. Volume
1.39%
Low Impact
1-Year Change
-75.6%
Negative Trend
FTD Chart
As of May 14, 2025,
SAB Biotherapeutics Inc. has
290
shares failed to deliver, representing 1.39%
of the average daily volume of
20,868.554
shares. Over the past year, the monthly average FTD is
1,433
shares, with the current level 80% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| May 14, 2025 | 0.02 | 290 | +480.00% |
| Apr 30, 2025 | 0.03 | 50 | -75.00% |
| Mar 28, 2025 | 0.03 | 200 | -88.05% |
| Feb 26, 2025 | 0.04 | 1.67K | +7509.09% |
| Jan 31, 2025 | 0.03 | 22 | +2100.00% |
| Dec 31, 2024 | 0.08 | 1 | -99.91% |
| Nov 29, 2024 | 0.07 | 1.13K | +2076.92% |
| Oct 17, 2024 | 0.04 | 52 | -91.36% |
| Sep 26, 2024 | 0.04 | 602 | -94.66% |
| Aug 29, 2024 | 0.05 | 11.27K | +5618.27% |
| Jul 30, 2024 | 0.03 | 197 | -96.00% |
| Jun 28, 2024 | 0.04 | 4.92K | +1373.95% |
| May 30, 2024 | 0.04 | 334 | -67.88% |
| Mar 27, 2024 | 0.04 | 1.04K | +22.21% |
| Feb 29, 2024 | 0.03 | 851 | +61.17% |
| Jan 12, 2024 | 0.03 | 528 | +428.00% |
| Dec 27, 2023 | 0.04 | 100 | -94.99% |
| Nov 02, 2023 | 0.10 | 2K | n/a |
| Oct 31, 2023 | 0.06 | 2K | +330.89% |
| Sep 22, 2023 | 0.09 | 463 | +2336.84% |
| Jul 19, 2023 | 0.10 | 19 | -66.07% |
| Jun 28, 2023 | 0.12 | 56 | -98.09% |
| Apr 20, 2023 | 0.05 | 2.94K | +2058.82% |
| Mar 21, 2023 | 0.05 | 136 | -82.27% |
| Feb 28, 2023 | 0.05 | 767 | -45.21% |
| Jan 31, 2023 | 0.07 | 1.4K | n/a |